Nymox Pharmaceutical Stock Price - NYMX

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ and Amex.
Monthly Subscription
for only
$47.99
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$30.00
Ultimate Trader (Monthly)
Monthly Subscription
for only
$65.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Nymox Pharmaceutical Corp. (MM) NYMX NASDAQ Common Stock BSP733981026
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.02 -0.62% 3.21 3.27 3.18 - 3.23 20:00:00
Bid Price Ask Price Spread Spread % News
3.11 4.25 1.14 26.82% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
118 33,457 $ 3.2296 $ 108.05k 123.38k 1.62 - 5.79
Last Trade Time Type Quantity Stock Price Currency
16:00:00 201 $3.21 USD

Nymox Pharmaceutical Corp. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 153.68M 47.88M $ -17.88M -0.48 0.00 25.85M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.4M $ 0.00 0.00% - 1.70%

more financials information »

Nymox Pharmaceutical Corp. (MM) News

Date Time Source News Article
11/29/201609:45GlobeNewswire Inc.Nymox Reports Additional Positive Results From Completed..
11/23/201615:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)
11/15/201613:56Edgar (US Regulatory)Report of Foreign Issuer (6-k)
10/11/201610:00GlobeNewswire Inc.Nymox Reports Successful New Phase 3 Long-Term Fexapotide..
8/29/201610:30GlobeNewswire Inc.Nymox's New Phase 3 Long-Term U.S. Results For Prostate..
8/24/201612:19GlobeNewswire Inc.Nymox Reports Successful New Long-Term Fexapotide Placebo..
8/23/201612:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)

Historical NYMX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week3.303.483.180.000033k110k77k-0.09-2.73%
1 Month3.553.803.180.000022k133k80k-0.34-9.58%
3 Months2.724.002.670.000022k774k124k0.4918.01%
6 Months3.494.732.670.000022k7M211k-0.28-8.02%
1 Year2.255.791.620.000014k18M485k0.9642.67%
3 Years5.505.790.320.0000028M524k-2.29-41.64%
5 Years8.328.52780.320.0000028M340k-5.11-61.42%

Nymox Pharmaceutical Corp. (MM) Description

Nymox Pharmaceutical Corporation is a biopharmaceutical company, engaged in R&D & sale of drugs for the aging population. It offers products such as AlzheimAlert™, NicAlert™ & TobacAlert™ & is developing NX-1207 for benign prostatic hyperplasia.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170325 23:47:18